Virtus LifeSci Biotech Products ETF (BBP)

Assets	$20.59M
Expense Ratio	0.79%
PE Ratio	n/a
Shares Out	350,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	+10.78%

Volume	402
Open	58.20
Previous Close	59.10
Day's Range	58.20 - 58.21
52-Week Low	45.00
52-Week High	63.25
Beta	0.90
Holdings	65
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

19.02% of assets

Name	Symbol	Weight
Alnylam Pharmaceuticals, Inc.	ALNY	2.43%
Mirum Pharmaceuticals, Inc.	MIRM	2.05%
Sarepta Therapeutics, Inc.	SRPT	2.02%
Ionis Pharmaceuticals, Inc.	IONS	1.85%
Ardelyx, Inc.	ARDX	1.83%
Travere Therapeutics, Inc.	TVTX	1.82%
Axsome Therapeutics, Inc.	AXSM	1.77%
United Therapeutics Corporation	UTHR	1.77%
Ironwood Pharmaceuticals, Inc.	IRWD	1.74%
Insmed Incorporated	INSM	1.74%